immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]

位置：首页 > 产品库 > immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]

立即咨询

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

包装与价格：

包装	价格(元)
1mg	询价
5mg	询价
10mg	询价
25mg	询价

Immunoglobulin light chain fragment

别名	H2N-Leu-Leu-Ile-Tyr-Trp-Ala-Ser-Thr-Arg-OH
Canonical SMILES	NC(CC(C)C)C(NC(CC(C)C)C(NC(C(C)CC)C(NC(CC1=CC=C(O)C=C1)C(NC(CC2=CNC3=C2C=CC=C3)C(NC(C)C(NC(CO)C(NC(C(O)C)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
分子式	C₅₄H₈₃N₁₃O₁₃
分子量	1122.32
溶解度	≥ 112.2mg/mL in DMSO
储存条件	Store at -20℃
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品描述	Immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus] is a fragment (Leu-Leu-Ile-Tyr-Trp-Ala-Ser-Thr-Arg) on the variable region of the human and mouse immunoglobulin light chain. Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule is made up of 2 identical heavy chains and 2 identical light chains joined by disulfide bonds so that each heavy chain is linked to a light chain and the 2 heavy chains are linked together. On each of the light chain, there is one variable region and a constant region. The variable region is the most important for binding to antigens. The antigen combining site of an antibody is made up of the variable regions of one light chain and one heavy chain. Within the variable regions, typically comprising 105-110 amino acids, some positions show more sequence variation than others. The variable fragments are the smallest fragment made from enzymatic cleavage of IgG and IgM class antibodies. References: 1. Janeway CA, Jr et al. (2001). Immunobiology. (5th ed.). Garland Publishing. ISBN 0-8153-3642-X 2. Woof J, Burton D (2004). “Human antibody-Fc receptor interactions illuminated by crystal structures”. Nat Rev Immunol 4 (2): 89–99. doi :10.1038/nri1266. PMID 15040582. 3. Mattu T, Pleass R, Willis A, Kilian M, Wormald M, Lellouch A, Rudd P, Woof J, Dwek R (1998). “The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions”. J Biol Chem 273 (4): 2260–72. doi:10.1074/jbc.273.4.2260. PMID 9442070. 4. Roux K (1999). “Immunoglobulin structure and function as revealed by electron microscopy”. Int Arch Allergy Immunol 120 (2): 85–99. doi :10.1159/000024226. PMID 10545762. 5. Barclay A (2003). “Membrane proteins with immunoglobulin-like domains–a master superfamily of interaction molecules”. Semin Immunol 15 (4): 215–23. doi :10.1016/S1044-5323(03)00047-2. PMID 14690046 . 6. Putnam FW, Liu YS, Low TL (1979). “Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain”. J Biol Chem 254 (8): 2865–74. PMID 107164. 7. Huber R (1980). “Spatial structure of immunoglobulin molecules”. Klin Wochenschr 58 (22): 1217–31. doi :10.1007/ BF01478928 6780722.